Hong Kong's CK Hutchison said late on Monday that its closely monitored ports deal would strictly adhere to all required ...

SYDNEY (Reuters) -Chinese battery maker CATL is set to price its shares at HK$263 ($33.70) each in the company's Hong Kong ...

Asia-Pacific markets are set to mostly rise Monday over optimism that U.S.-China trade tensions could de-escalate following ...

By Scott Murdoch (Reuters) -Chinese battery manufacturer CATL aims to raise at least HK$31.01 billion ($3.99 billion) in its ...

City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

SYDNEY: Chinese battery maker CATL is set to price its shares at HK$263 ($33.70) each and increase the size of the company's ...

Graphex Group Limited ("Graphex Group” or the "Company”) (HKSE: 6128)) announced today that the NYSE American LLC (the "New ...

Asian shares are higher after two days of trade talks between China and the U_S_ made what the U_S_ side said was ...